gptkbp:instance_of
|
gptkb:drug
|
gptkbp:bfsLayer
|
4
|
gptkbp:bfsParent
|
gptkb:ketoconazole
|
gptkbp:approves
|
gptkb:1981
gptkb:FDA
|
gptkbp:brand
|
gptkb:Nizoral
|
gptkbp:class
|
azole antifungal
|
gptkbp:contraindication
|
liver disease
allergy to ketoconazole
|
gptkbp:countermeasures
|
gptkb:battle
|
gptkbp:dosage_form
|
oral
topical
|
gptkbp:formulation
|
gptkb:tablet
gptkb:skincare_product
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nizoral
|
gptkbp:ingredients
|
gptkb:ketoconazole
|
gptkbp:interacts_with
|
gptkb:warfarin
benzodiazepines
certain statins
|
gptkbp:is_available_in
|
gptkb:various_countries
|
gptkbp:is_used_for
|
fungal infections
|
gptkbp:manager
|
topical application
oral ingestion
|
gptkbp:manufacturer
|
gptkb:Johnson_&_Johnson
|
gptkbp:marketed_as
|
gptkb:Nizoral_cream
gptkb:Nizoral_tablets
Nizoral shampoo
|
gptkbp:previous_name
|
gptkb:ketoconazole
|
gptkbp:requires
|
gptkb:battle
|
gptkbp:side_effect
|
headache
nausea
skin irritation
dry skin
itching
|
gptkbp:storage
|
room temperature
away from moisture
|
gptkbp:treatment
|
gptkb:tinea_corporis
seborrheic dermatitis
candidiasis
tinea pedis
tinea cruris
|